newsfilter
← Latest News
GlobeNewswire·

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Cellectis ((Euronext Growth: ALCLS, NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene